Literature DB >> 9625729

Characterization of hemoglobin adducts from a 4, 4'-methylenedianiline metabolite evidently produced by peroxidative oxidation in vivo.

A Kautiainen1, C A Wachtmeister, L Ehrenberg.   

Abstract

4,4'-Methylenedianiline (MDA) is a widely used mutagenic and carcinogenic industrial chemical. It is also a metabolite of 4, 4'-methylenediphenyl diisocyanate (MDI), which is used in the manufacturing of polyurethane foams. Biomonitoring of MDA, like other aromatic amines, is mainly carried out by GC/MS measurement of cysteine adducts in Hb from the nitroso metabolite, released by alkaline hydrolysis. In the present study it was investigated whether the formation of Hb adducts from non-nitroso metabolites of MDA can be used for the dosimetry of MDA. The study was carried out by treatment of mice with MDA and tritiated MDA or deuterated MDA and by identification of their products of reaction with Hb, after enzymatic hydrolysis of the globin and enrichment of the adducts. The main adduct, about 50% of the total amount of MDA associated with Hb, was characterized by MS and was shown to be a reaction product of MDA and the amino group of N-terminal valine in Hb, the derived structure being 1-[(4-imino-2, 5-cyclohexadien-1-ylidene)methyl]benzene-4-azo-2-isovaleric acid. It is likely that this quinonoid MDA imine adduct to valine was formed by an attack of a metabolite formed through peroxidative oxidation of MDA, in analogy with earlier observed oxidation of some other aromatic amines, e.g., benzidine. The reactive intermediate is suggested to be [(4-imino-2, 5-cyclohexadien-1-ylidene)methyl]-4-aminobenzene. The formation of the adduct was confirmed by incubating MDA with valine methyl ester in vitro in the presence of H2O2 and lactoperoxidase. Further, the same adduct was detected in MDI-exposed and control rats, the level in the exposed animals being about 60 times higher than in the controls. This study indicates that, at least in the mouse, extrahepatic peroxidative metabolism is an important pathway for the bioactivation of MDA, possibly leading to a genotoxic reactive intermediate. This study also demonstrates the usefulness of Hb adduct analysis for the identification of reactive intermediates in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9625729     DOI: 10.1021/tx9701485

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  5 in total

1.  Influence of polymorphic metabolic enzymes on biotransformation and effects of diphenylmethane diisocyanate.

Authors:  Margareta Littorin; Saimei Hou; Karin Broberg; Jonas Björk; Susanne Fält; Galbani Abdoulaye; Malgorzata Kalemba; Charlotta Ryk; Staffan Skerfving
Journal:  Int Arch Occup Environ Health       Date:  2007-08-04       Impact factor: 3.015

2.  Characterization of biliary conjugates of 4,4'-methylenedianiline in male versus female rats.

Authors:  Kan Chen; Richard B Cole; Vicente Santa Cruz; Ernest W Blakeney; Mary F Kanz; Tammy R Dugas
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-01       Impact factor: 4.219

3.  Role of COX-2 in the bioactivation of methylenedianiline and in its proliferative effects in vascular smooth muscle cells.

Authors:  Valeria Y Hebert; Brandon Chad Jones; Randy C Mifflin; Tammy R Dugas
Journal:  Cardiovasc Toxicol       Date:  2011-12       Impact factor: 3.231

4.  4,4'-methylenedianiline-induced hepatotoxicity is modified by N-acetyltransferase 2 (NAT2) acetylator polymorphism in the rat.

Authors:  Xiaoyan Zhang; Jason C Lambert; Mark A Doll; Jason M Walraven; Gavin E Arteel; David W Hein
Journal:  J Pharmacol Exp Ther       Date:  2005-09-28       Impact factor: 4.030

5.  Liquid chromatography-electrospray tandem mass spectrometry investigations of fragmentation pathways of biliary 4,4'-methylenedianiline conjugates produced in rats.

Authors:  Kan Chen; Tammy R Dugas; Richard B Cole
Journal:  Anal Bioanal Chem       Date:  2008-03-30       Impact factor: 4.142

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.